Charles A. Rowland Jr - Sep 13, 2022 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role: Director
Signature: /s/ Jennifer Elliott, Attorney-in-Fact
Stock symbol: GBIO
Transactions as of: Sep 13, 2022
Transactions value $: $127,404
Form type: 4
Date filed: 9/15/2022, 04:07 PM
Previous filing: Jun 13, 2022
Next filing: Sep 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GBIO	Common Stock	Purchase	$97.8K	+18.8K	+18.59%	$5.20	120K	Sep 13, 2022	Direct	F1
transaction	GBIO	Common Stock	Purchase	$29.7K	+5.6K	+4.67%	$5.30	125K	Sep 14, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.08 to $5.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.40, inclusive.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.08 to $5.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.40, inclusive.